Omidria (Omeros Corporation)
Welcome to the PulseAid listing for the Omidria drug offered from Omeros Corporation. This alpha-1 Adrenergic Agonist [EPC],Adrenergic alpha1-Agonists [MoA],Cyclooxygenase Inhibitors [MoA],Nonsteroidal Anti-inflammatory Compounds [Chemical/Ingredient],Nonsteroidal Anti-inflammatory Drug [EPC],Cyclooxygenase Inhibitor [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Omeros Corporation |
| NON-PROPRIETARY NAME: | phenylephrine and ketorolac |
| SUBSTANCE NAME: | PHENYLEPHRINE; KETOROLAC |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | alpha-1 Adrenergic Agonist [EPC],Adrenergic alpha1-Agonists [MoA],Cyclooxygenase Inhibitors [MoA],Nonsteroidal Anti-inflammatory Compounds [Chemical/Ingredient],Nonsteroidal Anti-inflammatory Drug [EPC],Cyclooxygenase Inhibitor [EPC] |
| ROUTE: | INTRAOCULAR |
| DOSAGE FORM: | INJECTION, SOLUTION, CONCENTRATE |
| MARKETING CATEGORY NAME: | NDA |
| START MARKETING DATE: | 2014-06-13 |
| END MARKETING DATE: | 0000-00-00 |
Omidria HUMAN PRESCRIPTION DRUG Details:
| Item Description | Omidria from Omeros Corporation |
| LABELER NAME: | Omeros Corporation |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 10.16; 2.88(mg/mL; mg/mL) |
| START MARKETING DATE: | 2014-06-13 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 62225-600_39475819-b338-1dd0-e054-00144ff8d46c |
| PRODUCT NDC: | 62225-600 |
| APPLICATION NUMBER: | NDA205388 |
Other PHENYLEPHRINE; KETOROLAC Pharmaceutical Manufacturers / Labelers:
